.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Postmenopausal bone health requires risk-based assessment rather than relying only on calcium or vitamin D supplementation. Large randomized studies have shown that supplementation can modestly influence bone density but does not eliminate fracture risk and may have adverse effects when used excessively. For clinicians, prevention should combine assessment of fracture risk, adequate dietary calcium, vitamin D sufficiency, weight-bearing activity, fall prevention and pharmacologic therapy when indicated. Menopause care therefore benefits from an integrated approach rather than treating bone density as a separate problem. Women at high fracture risk may require bisphosphonates or other osteoporosis therapies based on age, prior fractures and calculated risk. The evidence supports using supplementation to correct deficiency rather than assuming that more calcium automatically produces better outcomes.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Postmenopausal bone health requires risk-based assessment rather than relying only on calcium or vitamin D supplementation. Large randomized studies have shown that supplementation can modestly influence bone density but does not eliminate fracture risk and may have adverse effects when used excessively. For clinicians, prevention should combine assessment of fracture risk, adequate dietary calcium, vitamin D sufficiency, weight-bearing activity, fall prevention and pharmacologic therapy when indicated. Menopause care therefore benefits from an integrated approach rather than treating bone density as a separate problem. Women at high fracture risk may require bisphosphonates or other osteoporosis therapies based on age, prior fractures and calculated risk. The evidence supports using supplementation to correct deficiency rather than assuming that more calcium automatically produces better outcomes.
4 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
